Trial Profile
A Retrospective Survey to Evaluate the Renoprotective Effect of Losartan in Type II Diabetic Patients With Microalbuminuria and Hypertension in Real Life.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Diabetic nephropathies; Hypertension in diabetes; Proteinuria; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Organon
- 13 Jul 2011 New trial record